KAVITHA RAMAN: Open Payments
NPI 1548922602 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 41 payments from 11 companies in 2025. Trend: 2023 $28 · 2024 $76 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 15 | $230 |
| TerSera Therapeutics LLC | 7 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $124 |
| BIOTRONIK NRO, Inc. | 1 | $104 |
| Valinor Pharma, LLC | 4 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $68 |
| Nalu Medical, Inc. | 2 | $39 |
| Averitas Pharma Inc. | 1 | $30 |
| Curonix LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: Prialt, Nucynta, RELISTOR, Prospera, MOVANTIK, XTAMPZA, JOURNAVX, Nalu Neurostimulation System.
Industry payments across TX — which companies pay providers there.
